You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Tasman Pharma Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for TASMAN PHARMA, and what generic alternatives to TASMAN PHARMA drugs are available?

TASMAN PHARMA has two approved drugs.

There is one US patent protecting TASMAN PHARMA drugs.

There are six patent family members on TASMAN PHARMA drugs in six countries.

Summary for Tasman Pharma
International Patents:6
US Patents:1

Drugs and US Patents for Tasman Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tasman Pharma CLOTRIMAZOLE clotrimazole SOLUTION;TOPICAL 212281-001 Jul 25, 2019 AT RX No No   Start Trial   Start Trial
Tasman Pharma VERSACLOZ clozapine SUSPENSION;ORAL 203479-001 Feb 6, 2013 RX Yes Yes 8,057,811   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.